Grünenthal voluntary admission: employee missed ABPI exam first-year deadline (Clause 9.4)

📅 2021 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/3799/7/23
CompanyGrünenthal
TypeVoluntary admission
IssueFailure to take the appropriate ABPI Examination within the first year of employment as a representative
Employee areaMarket Access (role entailed calling upon health professionals)
Applicable Code year2021
Breach clausesClause 9.4
Complaint received14 July 2023
Case completed12 August 2024
AppealNo appeal
SanctionsUndertaking received; additional sanctions: Not stated
Key dates mentionedEmployment start: February 2022; first module: 23 April 2023; should have taken modules by: 21 February 2023; passed within two years by: 21 February 2024

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Grünenthal made a voluntary admission about an employee in Market Access whose role involved calling on health professionals.
  • The employee started employment in February 2022 but did not start/take the appropriate ABPI Exam modules within the first year (first module completed 23 April 2023; modules should have been taken by 21 February 2023).
  • The issue was found during an internal monitoring exercise.
  • On investigation, the employee’s “start date in industry” had been entered incorrectly on the ABPI exams website (15 August 2022, said to be the date of the first in-field HCP call, rather than the actual start date).
  • No extension request was submitted when the first-year deadline was missed.
  • The employee subsequently completed and passed all modules within two years of the corrected start date (before 21 February 2024) and provided a certificate.
  • Grünenthal noted a gap in dedicated compliance resource for about one month (previous Compliance Officer left 28 April 2023; Interim Compliance Officer started 1 June 2023).
⚖️

Outcome

  • Breach of Clause 9.4.
  • PMCPA Panel expressed concern about the lack of measures that could have prevented the issue and reiterated expectations for robust policies and procedures.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training